pharmaphorum July 21, 2020
The COVID-19 crisis has accelerated the shift to a more resilient, agile and innovative digitally-enabled world within healthcare and pharma. But the best companies are going further – by enhancing and expanding their digital channels they are using this as an opportunity for enduring change. Continuing our series on digital health and COVID-19, David Reilly examines major shifts in patient care and healthcare provision resulting from the pandemic and explores which of these changes are likely to stay.
Neurologists say that it takes around 90 days for new bridges to form between synapses in our brain. If we interpret this as the time for new habits to emerge, then we have now had long enough for our new behaviours in...
Today's Sponsors
Today's Sponsor